{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:18:56Z","timestamp":1778815136758,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People \nwith dermatomyositis (DM) or polymyositis (PM) often die from cancer, pulmonary, cardiac complications, or infections. In such cases, DM or PM might not be designated as the underlying cause of death (UCD) for mortality tabulation. In this study, we investigated DM\/PM mortality trends in the USA from 1981 to 2020 with respect to UCD and multiple causes of death (MCD) data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used the MCD data to identify all deaths with DM or PM mentioned anywhere on the death certificate and as the UCD in the USA from 1981\u20131982 to 2019\u20132020. We calculated age-adjusted mortality rates (AAMRs) and annual percentage changes (APCs) based on joinpoint regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 12,249 (3985 with DM and 7097 with PM) and 23,608 (8264 with DM and 15,344 with PM) people who died between 1981 and 2020 according to the UCD and MCD data, respectively. For DM, the APC was\u2009\u2212\u20096.7% (from 1981\u20131982 to 1985\u20131986),\u2009\u2212\u20090.1% (from 1985\u20131986 to 2003\u20132004), and\u2009\u2212\u20091.9% (from 2003\u20132004 to 2019\u20132020) according UCD and was\u2009\u2212\u20091.2% (from 1981\u20131982 to 2003\u20132004),\u2009\u2212\u20092.5% (from 2003\u20132004 to 2015\u20132016), and 2.8% (from 2015\u20132016 to 2019\u20132020) according MCD. For PM, the APC was 1.9% (from 1981\u20131982 to 1989\u20131990),\u2009\u2212\u20092.3% (from 1989\u20131990 to 2005\u20132006), and\u2009\u2212\u20095.2% (from 2005\u20132006 to 2019\u20132020) according UCD and was 1.3% (from 1981\u20131982 to 1991\u20131992) and\u2009\u2212\u20094.1% (from 1991\u20131992 to 2019\u20132020) according MCD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We identified two times as many DM\/PM deaths using the MCD as those identified using the UCD. Similar downward DM\/PM mortality trends were noted according to UCD and MCD. However, the year of significant decline in PM mortality was about 10\u00a0years earlier according to MCD than those according to UCD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02963-y","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:11:48Z","timestamp":1675145508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data"],"prefix":"10.1186","volume":"25","author":[{"given":"Pengyan","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hsueh","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"issue":"3","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","volume":"14","author":"I Marie","year":"2012","unstructured":"Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep. 2012;14(3):275\u201385.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2963_CR2","doi-asserted-by":"publisher","first-page":"101484","DOI":"10.1016\/j.berh.2019.101484","volume":"34","author":"S Baig","year":"2020","unstructured":"Baig S, Paik JJ. Inflammatory muscle disease \u2013 an update. Best Pract Res Clin Rheumatol. 2020;34(1):101484.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","volume":"45","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Garen T, Brunborg C, et al. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum. 2015;45(3):301\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2963_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","volume":"77","author":"GC Dobloug","year":"2018","unstructured":"Dobloug GC, Svensson J, Lundberg IE, Holmqvist M. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis. 2018;77(1):40\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s10067-019-04910-w","volume":"39","author":"X Yang","year":"2020","unstructured":"Yang X, Hao Y, Zhang X, et al. Mortality of Chinese patients with polymyositis and dermatomyositis. Clin Rheumatol. 2020;39(5):1569\u201379.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2963_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.semarthrit.2020.08.009","volume":"50","author":"L Li","year":"2020","unstructured":"Li L, D\u2019Silva KM, Lu N, et al. Mortality trends in polymyositis and dermatomyositis: a general population-based study. Semin Arthritis Rheum. 2020;50(5):834\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2963_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/RHU.0000000000001214","volume":"27","author":"H Muhammed","year":"2021","unstructured":"Muhammed H, Gupta L, Zanwar AA, et al. Infections are leading cause of in-hospital mortality in Indian patients with inflammatory myopathy. J Clin Rheumatol. 2021;27(3):114\u20139.","journal-title":"J Clin Rheumatol"},{"key":"2963_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24786","author":"VL Kronzer","year":"2021","unstructured":"Kronzer VL, Kimbrough BA, Crowson CS, et al. Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study. Arthritis Care Res (Hoboken). 2021. https:\/\/doi.org\/10.1002\/acr.24786.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"2963_CR9","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1093\/rheumatology\/keaa661","volume":"60","author":"KM D\u2019Silva","year":"2021","unstructured":"D\u2019Silva KM, Li L, Lu N, et al. Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study. Rheumatology (Oxford). 2021;60(6):2653\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2963_CR10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/art.1780261208","volume":"26","author":"MC Hochberg","year":"1983","unstructured":"Hochberg MC, Lopez-Acuna D, Gittelsohn AM. Mortality from polymyositis and dermatomyositis in the United States, 1968\u20131978. Arthritis Rheum. 1983;26(12):1465\u201371.","journal-title":"Arthritis Rheum"},{"key":"2963_CR11","unstructured":"Heron M. Deaths: Leading causes for 2019. National Vital Statistics Reports; Vol 70, No 9. Hyattsville, MD: National Center for Health Statistics, 2021. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr70\/nvsr70-09-508.pdf Accessed 24 Feb\u00a02022"},{"key":"2963_CR12","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Volume 2 Instruction Manual, Fifth Edition, 2016. Geneva: World Health Organization; 2016. https:\/\/icd.who.int\/browse10\/Content\/statichtml\/ICD10Volume2_en_2016.pdf. Accessed 4 Feb 2022"},{"key":"2963_CR13","unstructured":"National Center for Health Statistics. Public use data file documentation: mortality multiple cause-of-death. Hyattsville, MD: National Center for Health Statistics; https:\/\/www.cdc.gov\/nchs\/nvss\/mortality_public_use_data.htm. Accessed 4 Feb\u00a02022"},{"issue":"1","key":"2963_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/1471-2458-10-597","volume":"10","author":"AH Santo","year":"2010","unstructured":"Santo AH, Souza JM, Pinheiro CE, Souza DC, Sato EI. Trends in dermatomyositis- and polymyositis-related mortality in the state of S\u00e3o Paulo, Brazil, 1985\u20132007: multiple cause-of-death analysis. BMC Public Health. 2010;10(1):597.","journal-title":"BMC Public Health"},{"issue":"9","key":"2963_CR15","first-page":"1823","volume":"31","author":"JJ Sacks","year":"2004","unstructured":"Sacks JJ, Helmick CG, Langmaid G. Deaths from arthritis and other rheumatic conditions, United States, 1979\u20131998. J Rheumatol. 2004;31(9):1823\u20138.","journal-title":"J Rheumatol"},{"issue":"11","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M17-0102","volume":"167","author":"EY Yen","year":"2017","unstructured":"Yen EY, Shaheen M, Woo JM, Mercer N, Li N, McCurdy DK, Karlamangla A, Singh RR. 46-year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013: a nationwide population-based study. Ann Intern Med. 2017;167(11):777\u201385.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2963_CR17","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/jcm10081759","volume":"10","author":"A Rodriguez-Pla","year":"2021","unstructured":"Rodriguez-Pla A, Rossello-Urgell J. Trend and geographic disparities in the mortality rates of primary systemic vasculitis in the United States from 1999 to 2019: a population-based study. J Clin Med. 2021;10(8):1759.","journal-title":"J Clin Med"},{"issue":"10","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/acr.24411","volume":"73","author":"EY Yen","year":"2021","unstructured":"Yen EY, Singh DR, Singh RR. Trends in systemic sclerosis mortality over forty-eight years, 1968\u20132015: a US population\u2013based study. Arthritis Care Res (Hoboken). 2021Oct;73(10):1502\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2963_CR19","unstructured":"Klein RJ. Age adjustment using the 2000 projected US population. Department of Health & Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2001"},{"key":"2963_CR20","unstructured":"The National Cancer Institute. The Joinpoint Trend Analysis Software. https:\/\/surveillance.cancer.gov\/joinpoint\/ Accessed 4 Feb\u00a02022"},{"key":"2963_CR21","doi-asserted-by":"crossref","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335\u201351 (correction: 2001;20:655)","DOI":"10.1002\/sim.811"},{"key":"2963_CR22","doi-asserted-by":"publisher","unstructured":"Kronzer VL, Kimbrough BA, Crowson CS, Davis III JM, Holmqvist M, Ernste FC. Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study. Arthritis Care Res (Hoboken). First published Sep 21, 2021. https:\/\/doi.org\/10.1002\/acr.24786","DOI":"10.1002\/acr.24786"},{"issue":"11","key":"2963_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jclinepi.2005.03.009","volume":"58","author":"TH Lu","year":"2005","unstructured":"Lu TH, Walker S, Johansson LA, Huang CN. An international comparison study indicated physicians\u2019 habits in reporting diabetes in part I of death certificate affected reported national diabetes mortality. J Clin Epidemiol. 2005;58(11):1150\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"2963_CR24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/rheumatology\/keh717","volume":"44","author":"J Calvo-Alen","year":"2005","unstructured":"Calvo-Alen J, Alarc\u00f3n GS, Campbell R Jr, Fernandez M, Reveille JD, Cooper GS. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology. 2005;44(9):1186\u20139.","journal-title":"Rheumatology"},{"issue":"4","key":"2963_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0033354918777253","volume":"133","author":"T Falasinnu","year":"2018","unstructured":"Falasinnu T, Rossides M, Chaichian Y, Simard JF. Do death certificates underestimate the burden of rare diseases? The example of systemic lupus erythematosus mortality, Sweden, 2001\u20132013. Public Health Rep. 2018;133(4):481\u20138.","journal-title":"Public Health Rep"},{"issue":"5","key":"2963_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/acr.23010","volume":"69","author":"MC Kwa","year":"2017","unstructured":"Kwa MC, Ardalan K, Laumann AE, Nardone B, West DP, Silverberg JI. Validation of international classification of diseases codes for the epidemiologic study of dermatomyositis. Arthritis Care Res (Hoboken). 2017;69(5):753\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"S1","key":"2963_CR27","doi-asserted-by":"publisher","first-page":"keab247.088","DOI":"10.1093\/rheumatology\/keab247.088","volume":"60","author":"JR Hannah","year":"2021","unstructured":"Hannah JR, Gordon P, Galloway J, Peach EJ, Lanyon PC, Bythell M, Pearce FA. P090 Validation of hospital episode statistics data to enable national registration of idiopathic inflammatory myopathies. Rheumatology. 2021;60(S1):keab247.088. https:\/\/doi.org\/10.1093\/rheumatology\/keab247.088.","journal-title":"Rheumatology"},{"issue":"4","key":"2963_CR28","doi-asserted-by":"publisher","first-page":"e056441","DOI":"10.1136\/bmjopen-2021-056441","volume":"12","author":"SY Tai","year":"2022","unstructured":"Tai SY, Liang FW, Hng YY, Lo YH, Lu TH. Impacts of using different standard populations in calculating age-standardised death rates when age-specific death rates in the populations being compared do not have a consistent relationship: a cross-sectional population-based observational study on US state HIV death rates. BMJ Open. 2022;12(4):e056441.","journal-title":"BMJ Open"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02963-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02963-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02963-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:13:48Z","timestamp":1675145628000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02963-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02963-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of National Cheng Kung University Hospital. No participants were involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the final version of the manuscript and consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}